Fidelity Biosciences, Devonshire's tech arm form F-Prime

Fidelity Biosciences joined with the technology venture arm of Devonshire Investors to form F-Prime Capital. Devonshire is a private equity firm affiliated with Fidelity's parent company, FMR LCC. The firm said the re-branding would "clarify our mission" as a VC investor that is separate from Fidelity's mutual fund business.

Spokesperson Michael Aalto said Fidelity's investment strategies would remain unchanged following the name change, with investments in life sciences, healthcare and technology. ...